Company / Return on Assets (ROA)
Spero Therapeutics, Inc. Return on Assets (ROA) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-99.5%
FY2025
5-year range
-99.5% / 20.6%
FY2021-FY2025
Trend
-582.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) changed -582% YoY in FY2025, a notable deviation from the 7-year average annual change of -73%.
Based on SEC 10-K filings.
-99.5% in FY2025 with a 5-year CAGR of -59.8%.
Declined from -25.4% to -99.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -27.6pp
- 5-Year Change
- -59.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 582.3% year-over-year.
- Peak return on assets (roa) was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -99.5% | -582.3% |
| FY2024 | 20.6% | +181.1% |
| FY2023 | -25.4% | +64.6% |
| FY2022 | -71.9% | -57.1% |
| FY2021 | -45.8% | -15.3% |
| FY2020 | -39.7% | -1.0% |
| FY2019 | -39.3% | -98.9% |
| FY2018 | -19.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026